DFDA

Pulmonary Rehabilitation

Treatment for Asbestosis

Typical Dosage: 3-5 sessions per week, 30-60 minutes per session

Effectiveness
85%
Safety Score
95%
Clinical Trials
500
Participants
50K

Comparative Safety Scale(Higher is safer)

Cyanideâ˜ ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
3-5 sessions per week, 30-60 minutes per session
Time to Effect
6-12 weeks
Treatment Duration
8-12 weeks initial, then ongoing home program
Evidence Quality
HIGH
Number Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$500
Side Effect Mgmt:$0
Total Annual:$3,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
QALYs Gained
0.1
Outcome-Based Costs
Cost per Responder
$4,000
Prescription Access Economics
Annual Societal Loss per Patient
$220
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$150/year
Time Cost
$50/year
Travel + wait time
Insurance Admin Cost
$20/year
Prior auth, claims
Rx Price
$0/year
Risk Assessment
Misuse Risk
LOW
Missed Diagnosis Risk
LOW
Pulmonary Rehabilitation Outcomes

for Asbestosis

Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+75%
Common Side Effects
Muscle soreness
+30%
Fatigue
+15%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov